Beihua Kong
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- PARP inhibition in cancer therapy (24 papers)Ovarian cancer diagnosis and treatment (20 papers)RNA modifications and cancer (11 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Beihua Kong
95 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 118
- Molecular Biology 990
- Cancer Research 525
- Oncology 523
- Immunology 409
- Pulmonary and Respiratory Medicine 334
Countries citing papers authored by Beihua Kong
This map shows the geographic impact of Beihua Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beihua Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beihua Kong more than expected).
Fields of papers citing papers by Beihua Kong
This network shows the impact of papers produced by Beihua Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beihua Kong. The network helps show where Beihua Kong may publish in the future.
Co-authorship network of co-authors of Beihua Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Beihua Kong. A scholar is included among the top collaborators of Beihua Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beihua Kong. Beihua Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 16 | |
| 8 | 3 | |
| 9 | 19 | |
| 10 | 19 | |
| 11 | 11 | |
| 12 | 2 | |
| 13 | 67 | |
| 14 | 40 | |
| 15 | 17 | |
| 16 | 9 | |
| 17 | 44 | |
| 18 | 31 | |
| 19 | 62 | |
| 20 | 3 |
About Beihua Kong
Beihua Kong is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 99 papers that have together received 2.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (24 papers), Ovarian cancer diagnosis and treatment (20 papers) and RNA modifications and cancer (11 papers). The work is most often cited by research in Reproductive Medicine (313 citations), Obstetrics and Gynecology (287 citations) and Cancer Research (525 citations). Beihua Kong has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Kun Song, Qifeng Yang, Cunzhong Yuan, Xun Qu, Yan Shi, Qing Zhang, Gonghua Qi, Hanlin Ma, James Z. Xing and Jie Chen. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.